In vitro, Paquinimod reduced the chemotactic response of Ly6Chigh myeloid cells to recombinant S100A9 and CT26 tumor supernatant, strongly suggesting that Paquinimod might promote tumor growth through blocking chemotactic signals from tumor, through binding to S100A9. This evidence concerns the gene S100A9 and neoplasm.